Role for Proton Therapy in Locally Advanced Non–Small-Cell Lung Cancer?

Video

This video reviews results of a randomized trial comparing intensity modulated radiation therapy vs passively scattered proton therapy for locally advanced non–small-cell lung cancer.

In this video, Zhongxing Liao, MD, of MD Anderson Cancer Center in Houston, Texas, reviews results of a randomized trial that compared intensity modulated radiation therapy (IMRT) vs passively scattered proton therapy in patients with locally advanced non–small-cell lung cancer.

Liao gave a presentation on this topic earlier this year at the 2017 Multidisciplinary Thoracic Cancers Symposium.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
Video 4 - "Frontline Treatment for EGFR-Mutated Lung Cancer"
Related Content